Loading...

Major Indexes

Discounted Cash Flow (DCF) Analysis Unlevered


PDS Biotechnology Corporation

PDS Biotechnology Corporation (PDSB)

$1.98
0.27 (+15.79%)

Operating Data

Year
A/P
2016
Projected
2017
Projected
2018
Projected
2019
Projected
2020
Projected
2021
Projected
2022
Projected
2023
Projected
Revenue --------
Revenue (%)
EBITDA --------
EBITDA (%)
EBIT --------
EBIT (%)
Depreciation --------
Depreciation (%)

Balance Sheet Data

Year
A/P
2016
Projected
2017
Projected
2018
Projected
2019
Projected
2020
Projected
2021
Projected
2022
Projected
2023
Projected
Total Cash --------
Total Cash (%)
Account Receivables --------
Account Receivables (%)
Inventories --------
Inventories (%)
Accounts Payable --------
Accounts Payable (%)
Capital Expenditure --------
Capital Expenditure (%)

Weighted Average Cost Of Capital

Share price $ 1.98
Diluted Shares Outstanding 4.87
Cost of Debt
Tax Rate 5.17
After-tax Cost of Debt -0.21
Risk-Free Rate
Market Risk Premium
Cost of Equity 2.46
Total Debt -
Total Equity 9.64
Total Capital 9.64
Debt Weighting 0.00
Equity Weighting 100.00
Wacc

Build Up Free Cash

Year
A/P
2016
Projected
2017
Projected
2018
Projected
2019
Projected
2020
Projected
2021
Projected
2022
Projected
2023
Projected
Revenue --------
EBITDA --------
EBIT --------
Tax Rate 4.54%4.84%6.37%5.17%5.23%5.23%5.23%5.23%
EBIAT --------
Depreciation --------
Accounts Receivable --------
Inventories --------
Accounts Payable --------
Capital Expenditure --------
UFCF --------
WACC
PV UFCF --------
SUM PV UFCF -

Terminal Value

Growth in perpetuity method:
Long-term growth rate
WACC (%) 2.46
Free cash flow (t + 1) -
Terminal Value -
Present Value of Terminal Value -

Intrinsic Value

Enterprise Value -
Net Debt -
Equity Value -
Shares Outstanding 4.87
Equity Value Per Share -